COMMUNIQUÉS West-GlobeNewswire
-
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
21/10/2025 -
InnovAge to Announce Fiscal First Quarter 2026 Financial Results and Host Conference Call Tuesday, November 4, 2025
21/10/2025 -
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
21/10/2025 -
Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
21/10/2025 -
Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
21/10/2025 -
Medical Specialists of the Palm Beaches Unveils State-of-the-Art Medical Facility in Wellington, Florida
21/10/2025 -
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
21/10/2025 -
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
21/10/2025 -
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
21/10/2025 -
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure
21/10/2025 -
Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization
21/10/2025 -
Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook
21/10/2025 -
Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors
21/10/2025 -
KFSHRC réalise la première résection robotisée au monde d’une tumeur intracrânienne... Une nouvelle ère en neurochirurgie
21/10/2025 -
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
21/10/2025 -
Dermsquared Appoints April Armstrong, MD, MPH, as Editor-in-Chief of the Dermatology Online Journal
21/10/2025 -
Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
21/10/2025 -
Lighthouse Autism Center Appoints Joseph Giles as Chief Executive Officer and Chair of the Board
21/10/2025 -
CorVel Corporation to Host Live Earnings Release Webcast
21/10/2025
Pages